Recombinant Flagellin and Incomplete Freund’s Adjuvant Potentiate the Vaccine Efficacy of the Iron Acquisition Protein (HitA) of Pseudomonas aeruginosa

Elhosary, Mona Ahmed; El Guink, Nadia; AbdelBary, Amany; Aboushleib, Hamida Mostafa; Bahey-El-Din, Mohammed

doi:10.21608/aprh.2020.30543.1108

Recombinant Flagellin and Incomplete Freund’s Adjuvant Potentiate the Vaccine Efficacy of the Iron Acquisition Protein (HitA) of Pseudomonas aeruginosa

Journal of Advanced Pharmacy Research

Article 4, Volume 4, Issue 3, July 2020, Page 101-110 PDF (1.04 MB)

Document Type: Research Article

DOI: 10.21608/aprh.2020.30543.1108

View on SCiNiTO

Authors

Mona Ahmed Elhosary¹; Nadia El Guink¹; Amany AbdelBary²; Hamida Mostafa Aboushleib¹; Mohammed Bahey-El-Din ¹

¹Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt

²Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt

Abstract

Objectives: Pseudomonas aeruginosa is a notorious bacterial pathogen that can cause a variety of infections with high morbidity and mortality. The increasing multi-drug resistance of this pathogen makes it urgent to develop an effective vaccine. This study aimed at evaluation of the immunoadjuvant effect of flagellin (FliC) of Salmonella enterica and incomplete Freund’s adjuvant (IFA) on the protective vaccine efficacy of P. aeruginosa recombinant iron acquisition protein (HitA). Methods: In this work, recombinant HitA, FliC and fused FliC-F-HitA proteins were expressed in Escherichia coli after cloning their respective genes into pQE31 plasmid vector. The proteins were purified using metal affinity chromatography. The immunoadjuvant effect of FliC was examined upon mixing as well as fusion with HitA antigen of P. aeruginosa in the presence of incomplete Freund’s adjuvant (IFA). This was tested by active immunization followed by challenge using P. aeruginosa murine infection model. Results: Two weeks after the last immunization dose, serum samples were tested for antibody response which showed significant HitA-specific IgG antibody response in all immunized groups compared to control groups. A significant reduction in bacterial burden of lungs from mice immunized with HitA/FliC/IFA mixture was observed after challenge. Opsonophagocytic assay and liver histopathological examination confirmed the previous results. Conclusion: Overall, HitA recombinant protein is considered a promising vaccine candidate against P. aeruginosa upon mixing with S. enterica flagellin protein FliC and IFA.

Keywords

/Pseudomonas aeruginosa; Vaccine; HitA; Flagellin; FliC; Iron acquisition protein

Statistics
Article View: 278
PDF Download: 355

	Recombinant Flagellin and Incomplete Freund’s Adjuvant Potentiate the Vaccine Efficacy of the Iron Acquisition Protein (HitA) of Pseudomonas aeruginosa
Journal of Advanced Pharmacy Research
Article 4, Volume 4, Issue 3, July 2020, Page 101-110 PDF (1.04 MB)
Document Type: Research Article
DOI: 10.21608/aprh.2020.30543.1108
View on SCiNiTO
Authors
Mona Ahmed Elhosary¹; Nadia El Guink¹; Amany AbdelBary²; Hamida Mostafa Aboushleib¹; Mohammed Bahey-El-Din ¹
¹Department of Microbiology and Immunology, Faculty of Pharmacy, Alexandria University, Alexandria, Egypt
²Department of Pathology, Faculty of Medicine, Alexandria University, Alexandria, Egypt
Abstract
Objectives: Pseudomonas aeruginosa is a notorious bacterial pathogen that can cause a variety of infections with high morbidity and mortality. The increasing multi-drug resistance of this pathogen makes it urgent to develop an effective vaccine. This study aimed at evaluation of the immunoadjuvant effect of flagellin (FliC) of Salmonella enterica and incomplete Freund’s adjuvant (IFA) on the protective vaccine efficacy of P. aeruginosa recombinant iron acquisition protein (HitA). Methods: In this work, recombinant HitA, FliC and fused FliC-F-HitA proteins were expressed in Escherichia coli after cloning their respective genes into pQE31 plasmid vector. The proteins were purified using metal affinity chromatography. The immunoadjuvant effect of FliC was examined upon mixing as well as fusion with HitA antigen of P. aeruginosa in the presence of incomplete Freund’s adjuvant (IFA). This was tested by active immunization followed by challenge using P. aeruginosa murine infection model. Results: Two weeks after the last immunization dose, serum samples were tested for antibody response which showed significant HitA-specific IgG antibody response in all immunized groups compared to control groups. A significant reduction in bacterial burden of lungs from mice immunized with HitA/FliC/IFA mixture was observed after challenge. Opsonophagocytic assay and liver histopathological examination confirmed the previous results. Conclusion: Overall, HitA recombinant protein is considered a promising vaccine candidate against P. aeruginosa upon mixing with S. enterica flagellin protein FliC and IFA.
Keywords
/Pseudomonas aeruginosa; Vaccine; HitA; Flagellin; FliC; Iron acquisition protein


Statistics Article View: 278 PDF Download: 355